How Misaligned Pharma and Diagnostic Timelines Are Slowing Targeted Therapy Access
How New Oligonucleotide Modalities Are Reshaping Preclinical Development
Breaking Through Trial Complexity
Regulatory Consistency Enables Global Patient Access
The Missing Middle of Pharma Personalisation
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Single Use Technologies Are Changing Biopharmaceutical Production
For most of the biopharmaceutical industrys history a manufacturing plant was defined by its steel Gleaming tanks fixed piping and miles of welded lines were built to last for decades cleaned and sterilized between every batch and validated at great expense before a single dose left the building That model delivered the first generation of biologics but it was designed for a world of few products...
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Identification of flavonoids from natural products against hyperlipidaemia through computational approaches
Over the centuries hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease CVD Current research increasingly explores natural compounds such as flavonoids for their potential lipidlowering effects This study evaluated pharmacological potential
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
The Translational Gap Is Killing Your Best Molecules
Lakshmi
In an era of unprecedented scientific capability, the gap between promising preclinical data and clinical reality remains one of the industry's most persistent challenges.
-
2
Decentralized Clinical Trials: A Strategic Shift for Faster Drug Development
Lakshmi
Decentralized clinical trials were justified to boards as a cost reduction and have largely underdelivered against that promise. This article argues the real return is cycle time, and that the correct...
-
3
Adaptive Clinical Trials: Building Flexibility into Modern Drug Development
Lakshmi
Adaptive clinical trials are no longer methodologically controversial; the constraint has moved elsewhere. This article examines why most adaptive designs still sit in early phases, what a harmonized...
-
4
Biotech Breakthroughs and Pharma Frontiers: Emerging Modalities in Cancer Treatment
Subathra Ramamoorthy
A revolution is underway in cancer treatment, driven by novel modalities that promise greater precision and efficacy. This article examines paradigm-shifting approaches such as CAR-T cell therapy, bis...
-
5
Understanding Over-the-Counter (OTC) Drugs: Trends and Opportunities in Pharma
Kate Williamson
This article explores the growing role of over-the-counter (OTC) drugs in global healthcare, highlighting current trends such as increased health awareness, technological advancements, and an aging po...
press releasesRead more...
Takara Bio USA Collaborates with the Allen Institute to Enable Spatial Mapping Across Broader Brain Regions with the Trekker® Spatial Biology Platform
Takara Bio USA Inc a wholly owned subsidiary of Takara Bio Inc Takara Bio today announced a significant expansion of its Trekker SingleCell Spatial Mapping Kits with the introduction of largeformat tiles
Argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities
Argenx the immunology innovation company today announced a definitive agreement to acquire Unnatural Products Inc UNP adding a macrocyclic peptide discovery engine to its immunology innovation capabilities argenx which already holds a minority stake in UNP will acquire all remaining shares in a tran...
PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility
PharmaLogic Holdings Corp the only independent contract development and manufacturing organization CDMO of scale dedicated exclusively to radiopharmaceuticals today announced a definitive agreement to acquire the CDMO business and Springfield New Jersey manufacturing facility from Lantheus Holdings...
Sino Biological Advances AI-Designed Molecule Validation with 4RISE™
AI can generate protein candidates at an unprecedented speed but experimental validation remains essential to determine whether they properly express bind targets and demonstrate the desired biological properties Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in recombinant protein t...
Events Read more...
10 - 12
Nov 2026Lab Asset & Facility Management Summit
The Westin Boston Seaport Dist...
11 - 13
Nov 2026Frontiers in Cancer Science 2026
One Farrer Hotel,1 Farrer Park...
11 - 12
Nov 2026Medical Device Project and Portfolio Management
Chicago, IL, USA
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
LATEST NEWSRead more...
Oncolytics Biotech Signs Clinical Supply Agreement to Evaluate Pelareorep with LOQTORZI in Anal Cancer
Oncolytics Biotech Inc Nasdaq ONCY a clinicalstage immunotherapy company developing pelareorep has signed a clinical supply agreement with Coherus Oncology to evaluate pelareorep in combination with LOQTORZI toripalimabtpzi in patients with squamous cell anal carcinoma SCAC
MD Logic Health and Blu Vitals Launch Nine-Form Magnesium Supplement Mag 9+
MD Logic Health has partnered with Blu Vitals to launch Mag the first product developed through their collaboration The new magnesium supplement combines nine forms of magnesium with four additional nutrients in a daily formula designed to support energy production muscle and nerve function and bon...
PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed a Project Supply Agreement the Agreement with the North Denmark Region
PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed an agreement with Corealis Pharma Inc Corealis a GMPcompliant contract development
Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance
Thermo Fisher Scientific the world leader in serving science today introduces the Thermo Scientific AmpSure Universal SYBR Green and Probe Master Mixes Designed for everyday applications the mixes support reliable reproducible quantitative PCR qPCR performance and offer researchers a valuepriced opt...
Polaris Rx Selected by Bristol Myers Squibb to Dispense ZENBEXUS™ (iberdomide), the First FDA-Approved CELMoD Therapy for Multiple Myeloma
Polaris Rx announced today that it has been selected by Bristol Myers Squibb to dispense ZENBEXUS iberdomide the first cereblon E ligase modulator CELMoD therapy approved by the US Food and Drug Administration FDA ZENBEXUS is approved in combination with daratumumab
